对《儿童和青少年注意力缺陷多动障碍的药物治疗：欧洲不同指南的总结与概述》的勘误 - Suppr | 超能文献

Correction to: Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines.

作者信息

Van Vyve L, Dierckx B, Lim C G, Danckaerts M, Koch B C P, Häge A, Banaschewski T

机构信息

KU Leuven, Leuven, Belgium.

Erasmus MC, Rotterdam, The Netherlands.

出版信息

Eur J Pediatr. 2024 Mar;183(3):1057. doi: 10.1007/s00431-024-05426-5.

DOI:10.1007/s00431-024-05426-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Correction to: Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines.对《儿童和青少年注意力缺陷多动障碍的药物治疗：欧洲不同指南的总结与概述》的勘误

Eur J Pediatr. 2024 Mar;183(3):1057. doi: 10.1007/s00431-024-05426-5.

2

Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines.儿童和青少年注意缺陷多动障碍的药物治疗：不同欧洲指南的总结和概述。

Eur J Pediatr. 2024 Mar;183(3):1047-1056. doi: 10.1007/s00431-023-05370-w. Epub 2023 Dec 14.

3

Current issues around the pharmacotherapy of ADHD in children and adults.儿童和成人注意力缺陷多动障碍药物治疗的当前问题。

Pharm World Sci. 2009 Oct;31(5):509-516. doi: 10.1007/s11096-009-9302-3. Epub 2009 Jun 27.

4

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe.在欧洲针对儿童多动症的照料者观点调查中，接受药物治疗的多动症儿童/青少年的照料者负担相关因素。

Neuropsychiatr Dis Treat. 2017 Feb 7;13:373-386. doi: 10.2147/NDT.S121391. eCollection 2017.

5

The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.药物治疗对患有注意力缺陷/多动障碍青少年物质使用的影响：各亚型间的差异

Subst Use Misuse. 2017 Aug 24;52(10):1266-1274. doi: 10.1080/10826084.2016.1273955. Epub 2017 Mar 21.

6

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey.欧洲接受药物治疗的多动症儿童/青少年获得诊断、治疗和支持性服务的情况：来自“照顾者对儿童多动症的看法”调查的数据

Neuropsychiatr Dis Treat. 2017 Mar 30;13:947-958. doi: 10.2147/NDT.S128752. eCollection 2017.

7

Emotion dysregulation in adolescents is normalized by ADHD pharmacological treatment.青少年的情绪失调通过注意力缺陷多动障碍（ADHD）药物治疗得以正常化。

Borderline Personal Disord Emot Dysregul. 2025 Feb 3;12(1):3. doi: 10.1186/s40479-024-00268-x.

8

First-Time Users of ADHD Medication Among Children and Adolescents in Germany: An Evaluation of Adherence to Prescribing Guidelines Based on Claims Data.德国儿童和青少年中首次使用注意力缺陷多动障碍药物的情况：基于索赔数据对处方指南依从性的评估

Front Psychiatry. 2021 Apr 15;12:653093. doi: 10.3389/fpsyt.2021.653093. eCollection 2021.

9

The Caregiver Perspective on Paediatric ADHD (CAPPA) survey: Understanding sociodemographic and clinical characteristics, treatment use and impact of ADHD in Europe.照顾者对儿童多动症的看法（CAPPA）调查：了解欧洲多动症的社会人口统计学和临床特征、治疗使用情况及影响。

J Affect Disord. 2016 Aug;200:222-34. doi: 10.1016/j.jad.2016.04.011. Epub 2016 Apr 12.

10

Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.加拿大关于注意缺陷多动障碍、对立违抗障碍或品行障碍的儿童及青少年破坏性行为和攻击性行为药物治疗的指南。

Can J Psychiatry. 2015 Feb;60(2):62-76. doi: 10.1177/070674371506000204.

引用本文的文献

1

Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study.益生菌对儿童和青少年自闭症谱系障碍及/或注意力缺陷/多动障碍症状学的影响：初步研究

Res Child Adolesc Psychopathol. 2025 Feb;53(2):163-178. doi: 10.1007/s10802-024-01278-7. Epub 2025 Jan 11.